NIH Unperturbed by New Way of Peering into Personal Genomic Data
By Jocelyn Kaiser,
Science Insider
| 04. 10. 2012
In a provocative paper published this week, researchers say they have figured out a way to link a person's DNA to their anonymous genetic data in a certain kind of public research database. But the National Institutes of Health (NIH), which hosts one of the largest such databases, says it's not taking any new steps to prevent someone from using the method to breach privacy. That contrasts with NIH's response 4 years ago, when a similar study prompted the agency to pull genetic data from its public Web sites.
The issue then involved studies that compare DNA variants called single nucleotide polymorphisms (SNPs) in people with and without an illness to find disease risk markers. NIH had begun posting online pooled SNP results from hundreds of people, thinking privacy would not be breached. But then scientists reported in PloS Genetics that if they had a sample of an individual's DNA, they could link it to that person's SNP results within a public DNA pool. NIH (and the Wellcome Trust)
removed data from public sites; NIH now allows only approved...
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Patrick Foong, BioNews | 11.03.2025
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...